7-Year Outcome Finds Two-Level Cervical Disc Replacement Statistically Superior Option in Treating Disc Disease in New Journal of of Neurosurgery Paper by Dr. Todd Lanman

1
7-Year Outcome Finds Two-Level Cervical Disc
Replacement Statistically Superior Option in
Treating Disc Disease in New Journal of of
Neurosurgery Paper by Dr. Todd Lanman
2
For the first time ever, the breakthrough
two-level cervical disc replacement procedure
using the Prestige LP device has been found to be
a "statistically superior" option over fusion
surgery in treating degenerative disc disease in
two adjacent disc levels, in a new Journal of
Neurosurgery Spine clinical paper. The
peer-reviewed clinical paper documents the 7-year
outcome from the FDA approved clinical trial.
Dr. Todd H. Lanman
3
Following its published study last month
documenting favorable outcomes at 24 months
(two years) post-op of the FDA approved two-level
cervical disc replacement procedure using a
Prestige LP, the peer-reviewed medical journal,
Journal of Neurosurgery Spine, has published the
long-awaited long-term seven year study, noting
statistical superiority over fusion in treating
cervical degenerative disc disease in two
contiguous disc levels. This is the first time
ever that this breakthrough procedure has been
found to be statistically superior, in areas of
safety and effectiveness, to that of fusion
surgery, giving those suffering from cervical
disc disease in two adjacent disc levels another
option for treatment, and one that allows them to
maintain full mobility and motion in their neck
following a minimally invasive procedure.
4
The paper was authored by Todd H. Lanman, as lead
writer, along with five additional spine
surgeons, including J. Kenneth Burkus, MD,
Randall G. Dryer, MD, Matthew F. Gornet, MD,
Jeffrey R. McConnell, MD, and Scott D. Hodges,
DO. Lanman, who operates Beverly Hills-based
Lanman Spinal Neurosurgery (http//www.spine.md),
acted as Principal Investigator on the clinical
trial, which led to FDA approval last year, and
is widely sought out as one of the leading spine
surgeons and innovators in spine health and
artificial disc replacement in the world. As the
newly published paper notes, the study aimed to
assess long-term clinical safety and
effectiveness in patients undergoing anterior
cervical surgery using the Prestige LP artificial
disc replacement (ADR) prosthesis to treat
degenerative cervical spine disease in two
adjacent disc levels compared with anterior
cervical discectomy and fusion (ACDF).
5
The randomized controlled multicenter trial was
conducted at 30 US centers. At 84 months post-op,
Medtronics titanium ceramic composite Prestige
LP device demonstrated statistical superiority
over anterior cervical discectomy and fusion for
overall success. The study continued to compare
the clinical trials initial 209 investigational
patients undergoing a two-level cervical disc
replacement with that of 188 control patients
undergoing ACDF between June 2006 and November
2007 for 84 months postop. At the seven-year (84
month) postoperative mark, two-level cervical
disc replacement at two adjacent disc levels with
a Prestige LP device has been found to maintain
improved clinical outcomes and segmental motion,
and is now a safe and effective alternative to
fusion, as the paper notes.
6
As many patients suffer from multilevel disease,
or disease in more than one level of the cervical
spine, this procedure now allows for those
patients to undergo a procedure that restores
segmental motion in their neck, of which ACDF
normally limits, often times placing additional
stress on adjacent discs, potentially leading to
accelerated degeneration of those discs. As the
study also details, pseudoarthrosis in
multilevel ACDF is considerably higher than
single-level ACDF, as are revisions,
complications and reoperations.     One- or
two-level artificial disc replacement in the
cervical spine is approved by most insurance
plans. The published paper can be found
here http//thejns.org/doi/pdf/10.3171/2016.11.SP
INE16746
7
About Todd H. Lanman, MD. As a specialist in the
advancement of spinal health and surgery, total
disc replacement and motion preservation for more
than 25 years, Dr. Todd H. Lanman has earned top
honors, his patients trust and respect, and
recently was named one of the Top Doctors in
America. He is also the go-to Spinal Neurosurgeon
for many of the worlds leading business leaders
and biggest stars. A Diplomate of the American
Board of Neurological Surgery and a Fellow of the
American College of Surgeons, Dr. Lanman earned
his M.D. at Chicagos Northwestern University in
1983 with top honors and went on to complete his
residency in Neurological Surgery at University
of California at Los Angeles. Since then, Dr.
Lanman has led his leading spinal neurosurgery
practice, Lanman Spinal Neurosurgery, in the
heart of Beverly Hills, which is affiliated with
Cedars-Sinai Medical Centers Institute for
Spinal Disorders, UCLA Medical Center and Saint
Johns Medical Center.
8
As a leading innovator in medicine, as well as a
media educator and contributor, Lanman has
published more than a dozen peer-reviewed
articles, as well as book chapters on topics
relating to his field, and has presented more
than two dozen papers at national and regional
medical society meetings. His expertise is often
sought out as he is often tapped to be the
principal medical investigator on a wide swath of
clinical trials for motion preserving surgeries
and artificial disc replacement devices. He has
also remained an assistant clinical professor at
UCLA for the past 20 years. For more information
on Dr. Lanman and Lanman Spinal Neurosurgery,
visit http//www.spine.md/ References link
http//www.prweb.com/releases/2017/04/prweb142334
15.htm
9

• Contact us
• Cuellar Spine
• http//www.cuellarspine.com
• 450 N. Roxbury Drive 3rd Floor
  Beverly Hills, CA 90210